Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants

The purpose of this study is to characterize the pharmacokinetic (PK) of multiple twice-daily doses of JNJ-70033093 in healthy participants and to assess the effects of dosing time and food on the PK of single-dose of JNJ-70033093 in healthy participants.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - JNJ-70033093

JNJ-70033093 capsules will be administered orally .

Drug - Placebo

Matching placebo in capsule will be administered orally.

Additional Information

Official Study Title

A Phase 1, Open-label Single-dose Crossover, and Double-blind Multiple-dose Parallel Group Study to Characterize the Pharmacokinetics, Safety and Tolerability, and Pharmacodynamics of JNJ-70033093 in Healthy Adult Subjects

Clinical Trial ID

NCT04223349

ParticipAid ID

epYJra